CLINICAL AND ETIOLOGICAL PROFILE OF MALIGNANT ASCITES WITH SPECIAL REFERENCE TO SAAG CRITERIA AND BIOLOGICAL MARKERS
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i8.48849Keywords:
Malignant ascites, Malignant-related ascites, Biomarkers, Serum ascites-albumin gradientAbstract
Objective: The aim and objective of the study are to the analysis of the various patterns of malignant ascites (MA) in our setup.
Methods: This prospective observational study was conducted from November 2008 to August 2010 in the Postgraduate Department of General Medicine, S.C.B. Medical College, Cuttack. Diagnosed patients with ascites due to malignancy (intra-abdominal or extra-abdominal) were enrolled into the study. A thorough history and clinical examination were recorded. Patients underwent abdominal paracentesis in the first 24 h after the admission. Ascitic fluid was obtained from the left lower abdominal quadrant and samples were sent for biochemical, cytological, and microbiological analysis.
Results: Among 62 patients, male predominance was 71% and mean age of presentation was 55±20.5 years. Histopathological study revealed malignant cells in 32 cases in their ascitic fluid and was classified as MA or peritoneal carcinomatosis. In 30 patients, the ascitic fluid was negative for malignant cells and was classified as malignant-related ascites (MRA). The most common cancers causing MA were gastric (62.5%) followed by ovarian (25%). The most frequently associated cancers in MRA were hepatobiliary (53.3%) and ovarian (13.3%) cancers. Biomarkers were positive in total 32 cases. All 32 patients with carcinomatous peritonitis demonstrated a low (<1.1 mg/dL) serum ascites-albumin gradient (SAAG) and all 30 patients with MRA had high SAAG (>1.1 mg/dL).
Conclusion: The incidence of MA was 51.61% and MRA was 48.39%, and highest incidence was seen in the elderly males. SAAG was diagnostic in differentiating MA from MRA with an accuracy of 100%.
Downloads
References
Runyon BA. Cardiac ascites: A characterization. J Clin Gastroenterol 1988;10:410-2. doi: 10.1097/00004836-198808000-00013, PMID 3418089
Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988;8:1104-9. doi: 10.1002/ hep.1840080521, PMID 3417231
Khan FY. Ascites in the state of Qatar: Aetiology and diagnostic value of ascitic fluid analysis. Singapore Med J 2007;48:434-9. PMID 17453102
Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: A retrospective study. Ann Oncol 2007;18:945- 9. doi: 10.1093/annonc/mdl499. PMID 17298959
Parsons SL, Lang MW, Steele RJ. Malignant ascites: A 2-year review from a teaching hospital. Eur J Surg Oncol 1996;22:237-9. doi: 10.1016/ s0748-7983(96)80009-6, PMID 8654603
Johnson WD. The cytological diagnosis of cancer in serous effusions. Acta Cytol 1966;10:161-72. PMID 5227366
Cardozo PL. A Critical evaluation of 3000 cytologic analyses of pleural fluid, ascitic fluid, and pericardial fluid. Acta Cytol 1996;10:455-68.
Bhanvadia VM, Santwani PM, Vachhani JH. Analysis of diagnostic value of cytological smear method versus cell block method in body fluid cytology: Study of 150 cases. Ethiop J Health Sci 2014;24:125-31. doi: 10.4314/ejhs.v24i2.4, PMID 24795513
Published
How to Cite
Issue
Section
Copyright (c) 2023 Satya Prasad Samantaray
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.